GeneDx Holdings (WGS) EPS (Basic) Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 59.25% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 17.24% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 59.35% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.64% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -21.08% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -8.41% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 18.33% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.91% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | -257.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -257.88% |
| Mar 31, 2026 | -830.56% |
| Dec 31, 2025 | -403.95% |
| Sep 30, 2025 | 14.10% |
| Jun 30, 2025 | 134.52% |
| Mar 31, 2025 | 70.13% |
| Dec 31, 2024 | 119.15% |
| Sep 30, 2024 | 81.29% |
| Jun 30, 2024 | 40.39% |
| Mar 31, 2024 | 74.46% |
| Dec 31, 2023 | 96.49% |
| Sep 30, 2023 | 75.62% |
| Jun 30, 2023 | 78.06% |
| Mar 31, 2023 | 70.73% |
| Dec 31, 2022 | -145.78% |
| Sep 30, 2022 | -215.59% |
| Jun 30, 2022 | -126.58% |
| Mar 31, 2022 | 98.18% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |